Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
2.040
-0.030 (-1.45%)
Oct 2, 2026, 4:00 PM EDT - Market closed
Acumen Pharmaceuticals Market Cap
Acumen Pharmaceuticals has a market cap or net worth of $147.53 million as of October 2, 2026. Its market cap has increased by 39.17% in one year.
Market Cap
147.53M
Enterprise Value
68.98M
1-Year Change
39.17%
Ranking
Category
Stock Price
$2.04
ChartMarket Cap Chart
Since the IPO on July 1, 2021, Acumen Pharmaceuticals's market cap has decreased from $618.43M to $147.53M, a decrease of -76.14%. That is a compound annual growth rate of -23.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 147.53M | 15.43% |
| Dec 31, 2025 | 127.81M | 23.68% |
| Dec 31, 2024 | 103.34M | -53.53% |
| Dec 29, 2023 | 222.38M | 0.62% |
| Dec 30, 2022 | 221.00M | -19.22% |
| Dec 31, 2021 | 273.58M | -55.76% |
| Jul 1, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Precision BioSciences | 172.79M |
| PepGen | 167.61M |
| Tonix Pharmaceuticals Holding | 167.05M |
| Voyager Therapeutics | 165.14M |
| Minerva Neurosciences | 159.95M |
| NovaBridge Biosciences | 158.34M |
| Molecular Partners AG | 152.42M |
| Codexis | 152.21M |